Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander W Tas

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Annals of the Rheumatic Diseases|December 17, 2021
Hypoglycaemia following JAK inhibitor treatment in patients with diabetesJette A van Lint, Florence P A M van Hunsel, Sander W Tas, et al.
Drug Safety|May 27, 2020
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesJette A van Lint, Naomi T Jessurun, Renske C F Hebing, et al.
The Journal of Rheumatology|May 16, 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare ProfessionalsJette A van Lint, Naomi T Jessurun, Sander W Tas, et al.
Atherosclerosis|June 11, 2013
Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritisAart C Strang, Radjesh J Bisoendial, Ruud S Kootte, et al.
The Lancet. Rheumatology|July 3, 2023
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the NetherlandsLaura Boekel, Sadaf Atiqi, Maureen Leeuw, et al.
Rheumatology Advances in Practice|July 5, 2022
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patientsEbru Dirikgil, Sander W Tas, Cornelis A Verburgh, et al.
Arthritis Research & Therapy|August 31, 2023
CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritisWessel F Theeuwes, Irene Di Ceglie, Daphne N Dorst, et al.
The Lancet. Rheumatology|June 28, 2021
Adverse events after first COVID-19 vaccination in patients with autoimmune diseasesLaura Boekel, Laura Y Kummer, Koos P J van Dam, et al.
Frontiers in Immunology|March 15, 2024
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infectionSofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, et al.
Kidney International Reports|October 8, 2021
Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the NetherlandsEbru Dirikgil, Jacqueline T Jonker, Sander W Tas, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Annals of the Rheumatic Diseases|December 17, 2021
Hypoglycaemia following JAK inhibitor treatment in patients with diabetesJette A van Lint, Florence P A M van Hunsel, Sander W Tas, et al.
Drug Safety|May 27, 2020
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory DiseasesJette A van Lint, Naomi T Jessurun, Renske C F Hebing, et al.
The Journal of Rheumatology|May 16, 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare ProfessionalsJette A van Lint, Naomi T Jessurun, Sander W Tas, et al.
Atherosclerosis|June 11, 2013
Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritisAart C Strang, Radjesh J Bisoendial, Ruud S Kootte, et al.
The Lancet. Rheumatology|July 3, 2023
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the NetherlandsLaura Boekel, Sadaf Atiqi, Maureen Leeuw, et al.
Rheumatology Advances in Practice|July 5, 2022
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patientsEbru Dirikgil, Sander W Tas, Cornelis A Verburgh, et al.
Arthritis Research & Therapy|August 31, 2023
CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritisWessel F Theeuwes, Irene Di Ceglie, Daphne N Dorst, et al.
The Lancet. Rheumatology|June 28, 2021
Adverse events after first COVID-19 vaccination in patients with autoimmune diseasesLaura Boekel, Laura Y Kummer, Koos P J van Dam, et al.
Frontiers in Immunology|March 15, 2024
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infectionSofie Keijzer, Nienke Oskam, Pleuni Ooijevaar-de Heer, et al.
Kidney International Reports|October 8, 2021
Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in the NetherlandsEbru Dirikgil, Jacqueline T Jonker, Sander W Tas, et al.
Pageof 15